Japan Offers $1.16 Billion To Prod Drug Makers Into Regenerative Medicine
This article was originally published in PharmAsia News
Executive Summary
Japan's Prime Minister Shinzo Abe has focused his government on marketing regenerative medicine, backed by $1.16 billion in research funds, but his effort faces strong competition from abroad.